Skip to main content
Fig. 3 | BMC Veterinary Research

Fig. 3

From: Estimation of tulathromycin depletion in plasma and milk after subcutaneous injection in lactating goats using a nonlinear mixed-effects pharmacokinetic modeling approach

Fig. 3

Goodness-of-fit plots of plasma tulathromycin concentrations and milk cumulative excreted amounts of tulathromycin marker residue CP-60,300 in lactating goats. Comparisons between observed versus individual predicted tulathromycin concentrations or CP-60,300 amounts in the plasma (a) and milk (b), respectively

Back to article page

BMC Veterinary Research

ISSN: 1746-6148

Contact us